Department of Biomedical Sciences and Technology, School of Public Health and Community Development, Maseno University, Maseno, Kenya Kenya Medical Research Institute (KEMRI)-University of Minnesota Malaria Project, Center for Global Health Research, KEMRI, Kisumu, Kenya.
Kenya Medical Research Institute (KEMRI)-University of Minnesota Malaria Project, Center for Global Health Research, KEMRI, Kisumu, Kenya Department of Zoology, Faculty of Science, Maseno University, Maseno, Kenya.
Infect Immun. 2014 Sep;82(9):3775-82. doi: 10.1128/IAI.01924-14. Epub 2014 Jun 23.
Individuals naturally exposed to Plasmodium falciparum lose clinical immunity after a prolonged lack of exposure. P. falciparum antigen-specific cytokine responses have been associated with protection from clinical malaria, but the longevity of P. falciparum antigen-specific cytokine responses in the absence of exposure is not well characterized. A highland area of Kenya with low and unstable malaria transmission provided an opportunity to study this question. The levels of antigen-specific cytokines and chemokines associated in previous studies with protection from clinical malaria (gamma interferon [IFN-γ], interleukin-10 [IL-10], and tumor necrosis factor alpha [TNF-α]), with increased risk of clinical malaria (IL-6), or with pathogenesis of severe disease in malaria (IL-5 and RANTES) were assessed by cytometric bead assay in April 2008, October 2008, and April 2009 in 100 children and adults. During the 1-year study period, none had an episode of clinical P. falciparum malaria. Two patterns of cytokine responses emerged, with some variation by antigen: a decrease at 6 months (IFN-γ and IL-5) or at both 6 and 12 months (IL-10 and TNF-α) or no change over time (IL-6 and RANTES). These findings document that P. falciparum antigen-specific cytokine responses associated in prior studies with protection from malaria (IFN-γ, TNF-α, and IL-10) decrease significantly in the absence of P. falciparum exposure, whereas those associated with increased risk of malaria (IL-6) do not. The study findings provide a strong rationale for future studies of antigen-specific IFN-γ, TNF-α, and IL-10 responses as biomarkers of increased population-level susceptibility to malaria after prolonged lack of P. falciparum exposure.
个体在长时间缺乏暴露后,自然会失去对恶性疟原虫的临床免疫力。疟原虫抗原特异性细胞因子反应与预防临床疟疾有关,但在没有暴露的情况下,疟原虫抗原特异性细胞因子反应的持久性尚未得到很好的描述。肯尼亚高地地区疟疾传播率低且不稳定,为研究这一问题提供了机会。通过流式细胞术检测珠试验,评估了与以前研究中预防临床疟疾(γ干扰素[IFN-γ]、白细胞介素-10[IL-10]和肿瘤坏死因子-α[TNF-α])、增加临床疟疾风险(IL-6)或疟疾严重疾病发病机制(IL-5 和 RANTES)相关的抗原特异性细胞因子和趋化因子的水平。2008 年 4 月、2008 年 10 月和 2009 年 4 月对 100 名儿童和成人进行了评估。在 1 年的研究期间,没有人发生临床恶性疟原虫疟疾。两种细胞因子反应模式出现,不同抗原存在一定差异:6 个月时下降(IFN-γ和 IL-5)或 6 个月和 12 个月时均下降(IL-10 和 TNF-α)或随时间无变化(IL-6 和 RANTES)。这些发现表明,先前研究中与预防疟疾相关的疟原虫抗原特异性细胞因子反应(IFN-γ、TNF-α和 IL-10)在没有疟原虫暴露的情况下显著下降,而与疟疾风险增加相关的细胞因子(IL-6)则没有。研究结果为未来研究抗原特异性 IFN-γ、TNF-α和 IL-10 反应作为长时间缺乏恶性疟原虫暴露后人群易感性增加的生物标志物提供了有力依据。